What You Should Know:
– BrainScope, a neurotechnology company dedicated to transforming brain health diagnostics using computational neuroscience announced the appointment of Matt Adams as its new Chief Executive Officer.
– Adams succeeds Laurie Silver, who assumes the role of President and will continue to guide the company’s strategic direction and growth. Both leaders will serve on BrainScope’s Board of Directors.
Matt Adams Background
Matt Adams brings over two decades of experience leading MedTech companies through dynamic phases of innovation and scale, resulting in more than $1.3 billion in realized shareholder value. His expertise includes scaling global product portfolios, building AI-enabled platforms, and guiding high-value transactions across diagnostics, devices, and therapeutics.
Leadership Transition for Transformational Growth
The change in leadership comes at a pivotal moment for BrainScope. Laurie Silver was promoted to CEO two years ago with a clear mandate to position the company for sustained impact and scalability. Under her leadership, the company streamlined operations, transitioned its computational backbone into an innovative platform, and achieved a 50% year-over-year increase in brain injury assessment revenue.
BrainScope Chairman of the Board Ralph Terkowitz noted that Silver’s leadership has put the company on “firm financial footing” and that BrainScope is now “poised for transformational growth”.
“Matt’s ability to lead high-performing teams, drive clinical and commercial innovation, and scale businesses globally makes him exactly the right person for BrainScope at this stage,” Terkowitz added.
